top of page

Partner specialised in

  • DNA/RNA/Protein-microarray technology

  • ISO-compliant development

  • Rapid Test Systems

  • OEM Platform

#MIHfamily member

Speedy Molecular Diagnostics for Rapid Testing

They are responsible for compatibility testing of microfluidic chips and implementing quality control systems for large-scale manufacturing of In Vitro Diagnostic (IVD) chips. GENSPEED Biotech is ISO 13485 and ISO 9001 certified, specializing in the development, production, and distribution of rapid tests. Their technology platform, GENSPEED, is used for rapid detection of pathogens in periodontitis, nosocomial infections, and COVID-19. They have extensive expertise in DNA/RNA/Protein-microarray technology for detecting microorganisms and various biomarkers from clinical samples. Their team has also developed a microfluidic chip-based test system using chemiluminescence signal detection and passively driven microfluidics, with a strong background in microbiology, molecular biology, biochemistry, and biophysics.

Lab-on-a-cartridge system showcasing its modular components, sensor region, and various detection capabilities.

Biosensors for Food Safety & Public Health Monitoring

Development of a versatile lab-on-a-cartridge platform for rapid, multiplexed detection of pathogens like SARS-CoV-2 and Influenza, as well as contaminants in food. This innovative technology aims to enhance public health monitoring and ensure food safety through scalable and cost-effective diagnostics.

Image of DNA and Virus to showcase Scalable Molecular Diagnostics for SARS-CoV-2 with Advanced Microfluidic Chips.

Molecular Diagnostics for SARS-CoV-2

Sensor chip production for a molecular recognition platform in medical diagnostics in general and for SARS-CoV-2 diagnostics (both antibody and viral genetic material testing) in particular.

Infographic of Von Wille Brandt pathway and blood coagulation - by technoclone.

Shedding Light on Von Willebrand Disease: Technoclone's Pioneering Diagnostic Solution

In the intricate realm of blood disorders, Von Willebrand Disease (VWD) emerges as a prevalent yet often misunderstood condition. With Technoclone's latest initiative, the landscape of VWD diagnostics is on the brink of transformation, promising a future of enhanced accuracy, speed, and accessibility in patient care.

Illustration of ViroGates’ multiplex microfluidic chip and its integration into the GENSPEED® xPOC platform.

Advancing Patient Triage with ViroGates' Multiplex Inflammatory Biomarker Detection

ViroGates, an international in vitro diagnostics company based in Denmark, is renowned for its innovative solutions in emergency medicine. Their suPARnostic® product line, used extensively in emergency departments, enhances clinical decisions regarding the hospitalization or discharge of acute medical patients.

Photo of Hycult Biotech’s multiplex microfluidic chip and its integration into the GENSPEED® xPOC platform for CKD diagnostics.

Advancing Chronic Kidney Disease Diagnostics - Hycult Biotech's Complement Biomarker Assay

Hycult Biotech, together with the Microfluidics Innovation Hub, is developing a rapid, non-invasive multiplex assay for detecting complement activation markers in chronic kidney disease. This advanced microfluidic platform aims to improve early diagnosis and monitoring, offering a reliable alternative to invasive kidney biopsies

Contact us today and together we will evaluate which manufacturing process best suits your microfluidic needs! 

Are you ready to scale-up?

Contact us to discuss your microfluidic project requirements and objectives.


Partner Match

We connect you with the right manufacturing experts from our network.

We oversee the entire project, ensuring smooth coordination and timely delivery

Project Management

bottom of page